BioSpace News Archive

BIOASIS TECHNOLOGIES INC. is pleased to announce that Dr. Deborah Rathjen, Executive Chair will be attending and presenting at the following industry conferences.

Investigators from US Oncology Research, The US Oncology Network, and OntadaTM will share results from more than 30 studies exploring areas such as diffuse large B cell lymphoma, non-Hodgkin lymphoma, multiple myeloma and hematological adverse event management in the community oncology setting at the 63rd American Society of Hematology Annual Meeting and Exposition.

High adoption rate of home kits for diagnosis of HIV and increasing investment by private as well as government organizations to develop effective diagnostic techniques are factors driving growth of the HIV diagnostics market.

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced the launch of its Artificial Intelligence Academy, an innovative initiative that will bring to life an immersive learning experience for Moderna employees, in partnership with Carnegie Mellon University.